Humoral immunity to viruses and encapsulated bacteria is comprised of T cell-independent
The peripheral pool of mature B cells in adults is composed of several subpopulations, each of which is generally thought to make a distinct contribution to humoral immunity. As an ex ample, natural serum IgM functions as a first line of defense against pathogens and is pro duced primarily by B1a B cells before exposure (Baumgarth et al., 1999; Haas et al., 2005) . Upon bacterial or viral infection, marginal zone (MZ) and B1 B cell subsets respond rapidly, constituting the immediate acquired antibody response (Martin et al., 2001) . Finally, FO (fol licular) B cells dominate the delayed highly specific antibody response comprised by soma tically mutated higher affinity classswitched antibodies and memory B cells. These latter processes occur in germinal center reactions that occur after productive interactions between responding B cells and antigenspecific helper T cells McHeyzer Williams, 2003) .
The nature of the antigen itself can also dictate which B cell subset is recruited into an antibody response. Using model antigens in rodents, B cell antigens have been classified as either T cell independent (TI) or T cell depen dent (TD). TI antigens promote B cell prolifer ation, differentiation, and antibody production in the absence of T cells and are further clas sified into two subgroups: type I (TI1) or type 2 (TI2). TI1 antigens are mitogens that stimulate all B cells to produce antibody in a polyclonal manner and irrespective of an tigen specificity. Physiological TI1 antigens include Tolllike receptor (TLR) ligands, such as LPS which is expressed by gram negative bacteria (Coutinho et al., 1974) , or certain viral coat proteins (Berberian et al., 1993; Blutt et al., 2004) . TI2 antigens are instead com posed of repetitive epitopes displayed on a backbone that simultaneously engage multiple antigen receptors on the surface of antigen specific B cells. TI2 antigens elicit robust IgM and IgG3 antibody production in a TI fashion, although the presence of noncognate T cell help promotes production of other IgG iso types (Mongini et al., 1984) . These TI antigens include polysaccharides found on encapsulated bacteria and highly organized viral capsid pro teins such as those found on vesicular stomatitis virus and poliovirus (Bachmann et al., 1995;  result of innate immune receptor signaling contributes to regulating the antibody response.
It has been proposed that in addition to their antigen specific BCR, B cells may also use innate mechanisms for pathogen recognition. However, it is still unclear which of the innate receptors are used by B cells or what the conse quence of these signals is to the B cell antibody response. The rapid TI2 antibody response provides a temporal bridge be tween the early innate and late adaptive immune responses. Thus, we were interested to investigate how innate signals would augment the TI2 antibody response and influence the different B cell populations during this response.
In this paper, we show that TLR agonists significantly enhance the TI2 antibody response through the elaboration of type I IFN that promotes production of IgG2c by FO B cells. This contribution elicited by FO B cells is shown to accelerate the kinetics and enhance the magnitude and qual ity of the TI2 antibody response. Thus, these data not only provide a mechanistic example of how innate immunity influences adaptive immunity but also define how humoral immunity counters physiological pathogens that present TI2 antigens in the presence of ligands for innate immune receptors.
RESULTS

Poly(I:C) enhances the magnitude and kinetics of the TI-2 antibody response
Poly(I:C) is a synthetic doublestranded RNA (dsRNA) that mimics viral nucleic acids and is recognized by several innate PRRs, including the TLR3 receptor. MZ B cells are consid ered to be largely responsible for the antibody response to TI2 antigens (Martin et al., 2001 ) and express significantly higher levels of the TLR3 transcript than FO B cells (Genestier et al., 2007) . Thus, we questioned how poly(I:C) might in fluence the TI2 antibody response by immunizing mice with the model TI2 antigen NPFicoll in the presence or absence of poly(I:C). These results demonstrated that poly(I:C) markedly enhanced the antigenspecific IgG3 and IgG2c antibody responses at both day 4 and day 7 after immuniza tion ( Fig. 1 A) . In contrast, poly(I:C) did not alter the day4 IgM response but instead promoted a significant decrease in the NPspecific IgM response of 1.6fold at 7 d after immu nization ( Fig. 1 A) .
Overall, poly(I:C) led to a twofold increase in total antigenspecific Ig 7 d after immunization (Fig. 1 B) . The composition of the TI2 antigenspecific antibody response was skewed by poly(I:C) from an IgMdominated (61.3%) to an IgGdominated (81.6%) response ( Fig. 1 B) . However, poly(I:C) did not similarly enhance the magnitudes of all IgG subclasses but, rather, had the most striking effect on the NPspecific IgG2c response by accelerating the kinetics and increasing the magnitude of this isotype (Fig. 1, A 
and B).
Relative to other IgG isotypes, IgG2c is the least abundant isotype produced during the NPFicoll response in the absence of poly(I:C) (Fig. 1 B; Mongini et al., 1981 Mongini et al., , 1984 . Enhancement of the IgG2c response by poly(I:C) was dose dependent (Fig. S1 A) and, importantly, not a result of Fehr et al., 1998) . In con trast to TI antigens, TD antigens are generally monomeric soluble proteins that display single or few epitopes to antigen specific B cells and require cognate T cell help for induction of highly specific antibody responses generated through ger minal center reactions.
Although not absolute, a general division of labor is also acknowledged between B cell subsets and the response to TI2 and TD antigens. B1 and MZ B cell subpopulations have been considered to be primarily responsible for the antibody response to TI2 antigens (Fagarasan and Honjo, 2000; Martin et al., 2001; Balázs et al., 2002) , whereas FO B cells dominate antibody responses to soluble protein TD antigens. In accord with generating rapid antibody responses, MZ and B1 B cells have lower thresholds for activation com pared with FO B cells and are physically poised at sites either in tissues or at the blood-lymphoid interface that facilitates these early responses . B1 and MZ B cells are described as innate B cells in that they express a restricted repertoire of germlineencoded BCRs with poly reactive specificities (Bendelac et al., 2001) . Responding MZ B cells produce antigenspecific antibody at extrafollicular splenic sites early during the antibody response that is low af finity and predominantly IgM but also includes limited IgG subclasses. Although evidence exists that MZ B cells can also mount TD responses and initiate germinal center reactions (Song and Cerny, 2003; Phan et al., 2005) , the ability of FO B cells to directly participate in rapid extrafollicular TI2 anti body responses is minor (Ron and Sprent, 1985; Goud et al., 1988; Liu et al., 1988) .
Characterization of the TI2 antibody response has predominantly relied on haptencoupled carbohydrates as model antigens. However, physiological TI2 antigens would rarely be encountered in isolation but, rather, are typically associated with pathogenassociated molecular patterns (PAMPs) recognized by pattern recognition re ceptors (PRRs; Janeway, 1989; Snapper, 2006) . TLRs are one family of innate immune PRRs that have been shown to enhance the antibody response (Coutinho et al., 1974; Seppälä and Mäkelä, 1984; Sen et al., 2005; Heer et al., 2007; Rubtsov et al., 2008; EcklDorna and Batista, 2009 ). However, whether this regulation is physiologically rele vant has been controversial (Pasare and Medzhitov, 2005; Gavin et al., 2006) .
A major consequence of signaling by many PRRs is the rapid elaboration of inflammatory type I IFN cytokines (Baccala et al., 2007; McCartney and Colonna, 2009) , and many viral and bacterial infections lead to IFN/ produc tion (Bogdan, 2000; Mancuso et al., 2009) . Type I IFN has been previously characterized to modulate antibody production both in vitro and in vivo, including promoting classswitch recombination and polarizing antibody responses toward IgG2a/c production (Finkelman et al., 1991; Le Bon et al., 2001 , 2006 Coro et al., 2006; Heer et al., 2007) . How IFN / acts to effect these changes in humoral immunity is not well established, nor is whether the type I IFN produced as a somatic hypermutation . Given the rapid nature of the IgG2c antibody response induced by poly(I:C) to NPFicoll, we tested whether this would like wise be a lowaffinity extrafollicular response.
The primary antibody response to NPFicoll is dominated by Ig + NPspecific antibodies (Tesch et al., 1984) , thus we used Ig expression as a surrogate for NPspecific ASCs (Claassen et al., 1986; Jacob et al., 1991; García de Vinuesa et al., 1999; Shih et al., 2002) . NPFicoll alone elicited Ig + IgM-expressing ASCs localized to extrafollicular foci in the bridging channel of the red pulp (Fig. 2 B) as previously re ported (Claassen et al., 1986; García de Vinuesa et al., 1999; Shih et al., 2002) . NPFicoll + poly(I:C) induced not only extrafollicular Ig + IgM-expressing ASCs but also Ig + IgG2c-expressing ASCs within extrafollicular foci. Additionally, Ig + plasma cells that lacked IgM or IgG2c expression (Fig. 2 B) were also observed with poly(I:C) and are likely to be NP specific IgG3producing ASCs, as this isotype comprised a significant amount of the response (Fig. 1 B) .
The relative affinity of poly(I:C)induced NPspecific IgG2c antibodies was also measured and found to be com prised of relatively lowaffinity antibodies, which is similar to that produced in response to NPFicoll alone (Fig. 2 C) . In addition, this relative affinity did not increase with time indi cating the absence of affinity maturation (Fig. 2 C) . Thus, we show that poly(I:C) promotes a rapid IgG2c classswitched TI2 antibody response characterized by both extrafollicular antibody secretion and lowaffinity antibodies.
Both splenic and lymph node B cells participate in the poly(I:C)-elicited IgG2c antibody response to NP-Ficoll Measuring the frequency of splenic NPspecific IgG2c ASCs after immunization with poly(I:C) revealed a relative increase in the frequency of splenic NPspecific B cells that differ entiated into IgG2c ASCs (Fig. 3 A) . In accordance with anti body levels in serum (Fig. 1 A) , poly(I:C) also promoted a nonspecific antibody production by polyclonally activated B cells (Fig. S1 , B and C). Poly(I:C) alone did not induce either NPspecific IgG2c or total antigen nonspecific IgG2c. These results were confirmed by measuring the total IgG2c levels after immunization with NPFicoll ± poly(I:C) (Fig. S1 C) . Although poly(I:C) was found to increase total IgG2c serum levels on day 7, this increase was fully accounted for by the increase in NPspecific IgG2c at the same time point (Fig. 1 A) . Together, these results negate a role for polyclonal IgG2c antibody production and verify that poly(I:C) enhances the TI2 antibody response by an antigenspecific mechanism.
It is of note that IgG2c (IgG2a in Igh a expressing mouse strains) is not only the predominant Ig isotype generated in antiviral antibody responses (Coutelier et al., 1987) but is also considered a highly effective antipathogen Ig isotype Ravetch, 2005, 2008) . Thus, we restricted our subsequent focus to understanding the mechanism by which poly(I:C) altered the production of this IgG2c response.
Poly(I:C) augments the long-lived IgG2c TI-2 antibody response NPFicoll elicits relatively longlived serum NPspecific antibody responses in the absence of adjuvants (García de Vinuesa et al., 1999; Obukhanych and Nussenzweig, 2006) . We examined the adjuvant efficacy of poly(I:C) on this response and found that poly(I:C) significantly enhanced NPspecific IgG2c antibody levels at all time points evaluated (Fig. 2 A) . However, although the levels of longlived antigenspecific antibody were considerably increased, this did not result from an increased longevity of the antigenspecific IgG2c antibody response as the rate of decline of NPspecific IgG2c antibodies was similar regardless of poly(I:C) (Fig. 2 A) .
Poly(I:C) facilitates an extrafollicular and low-affinity IgG2c antibody response to NP-Ficoll TI2 antigens typically elicit a rapid extrafollicular antibody response with limited isotype class switching and without concomitant decline in the frequency of splenic NPspecific IgM ASCs. Furthermore, no significant differences were mea sured in the frequency of either NPspecific IgG2c or IgM ASCs in the bone marrow of mice regardless of poly(I:C) immunization (unpublished data).
Given the accelerated kinetics of the IgG2c response in duced by poly(I:C), we initially considered that MZ B cells destined to produce IgM were subverted to class switch to IgG2c during this TI2 response. However, antigenspecific IgG2c ASCs were also present in the lymph nodes of mice immunized with NPFicoll + poly(I:C) and were virtually absent in mice immunized with antigen alone (Fig. 3 B) . As MZ B cells do not normally recirculate in rodents Kumararatne et al., 1982) , the presence of lymph node NPspecific IgG2c ASCs indicated that a nonMZ popula tion contributed at least partially to the poly(I:C)induced IgG2c response. Although the capacity of lymph node B cells to respond to TI2 antigens has been shown (Ron and Sprent, 1985; Goud et al., 1988; Liu et al., 1988; Vinuesa et al., 2003) , this response is limited with respect to other B cell subsets (Martin et al., 2001; Balázs et al., 2002) . Thus, our data sug gest that innate signals augment the TI2 antibody response in part via enhanced production of antigenspecific IgG2c by lymph node B cells.
MZ B cells are not required for the IgG2c antibody responses to NP-Ficoll + poly(I:C)
B1 and MZ B cells are considered the major contributors to the TI2 antibody response (Fagarasan and Honjo, 2000; Martin et al., 2001 ). However, with regards to NPFicoll in particular, MZ B cells have been shown to be predominantly responsible for the TI2 antibody response (Otipoby et al., 1996; Guinamard et al., 2000; Samardzic et al., 2002; Shih et al., 2002) . Because MZ B cells are restricted to the spleen in rodents, we addressed whether MZ B cells contributed to the poly(I:C)induced IgG2c response by splenectomy and immunization with NPFicoll ± poly(I:C). As previously re ported (Amlot et al., 1985) , splenectomized mice mounted significantly reduced NPspecific IgM responses at days 4 and 7 after immunization with NPFicoll compared with sham operated animals and irrespective of poly(I:C) (Fig. 3 C) . Likewise, at day 7 the antigenspecific IgG2c response to NPFicoll alone was diminished approximately sevenfold in splenectomized mice (Fig. 3 C) . However, in the presence of poly(I:C) there was only a twofold reduction in the NPspecific IgG2c response measured in asplenic mice as compared with controls ( Fig. 3 C) . These data confirm MZ B cells are largely responsible for the NPFicoll IgM response and further show this is true in the presence of poly(I:C). Conversely, the small IgM and IgG2c antibody responses generated in asplenic mice highlight a minor role for FO B cells in the NPFicoll TI2 response (Ron and Sprent, 1985; Goud et al., 1988; Liu . Top panels show sections stained for Ig, IgM, and IgG2c. B cell follicles within the white pulp were revealed by IgM staining to provide orientation for the general lymphoid architecture. Top panels are 10× original magnification with enlarged areas within white outlined boxes represented in middle and bottom panels. Bottom panels depict only green Ig + ASCs and white arrows identify IgG2c ASCs. Bars, 50 µm. Data are representative of two independent experiments. (C) Relative affinity of NP-specific IgG2c antibodies was determined as the binding ratio of NP4/ NP16 and was measured by ELISA. Sera samples were analyzed from mice at 7, 14, and 31 d after immunization with NP-Ficoll or NP-Ficoll + poly(I:C). Results were combined from two independent experiments with four to eight mice per immunization group. Data are expressed as the arithmetic mean ± SEM. The NP-specific IgG2c mAb S43-10 was used as a positive control for a high-affinity binding antibody.
To provide further support for this notion, we used a second model in which the MZ B cell population was selec tively depleted by in vivo treatment with antiintegrin (4/L) antibodies (Lu and Cyster, 2002) while FO B cells were left et Vinuesa et al., 2003) . Collectively, our findings suggest that in the presence of poly(I:C), a B cell population distinct from MZ B cells is the predominant source of NP specific IgG2c. 
Poly(I:C) promotes FO B cells to participate in the IgG2c class-switched TI-2 antibody response
Our findings indicated that FO B cells contributed signifi cantly to the poly(I:C)induced NPFicoll response, although the capacity of lymph node B cells to contribute to the TI2 antibody response has been considered minimal (Ron and Sprent, 1985; Goud et al., 1988; Liu et al., 1988) . To directly examine if FO B cells mounted poly(I:C)induced IgG2c antibody responses to NPFicoll in vivo, we adoptively trans ferred lymph node cells from Igh B18/B18 (Igh a ) mice (Sonoda et al., 1997) into recipients and immediately assessed their ability to respond to NPFicoll ± poly(I:C). The B cells within the lymph node were phenotypically homogenous as CD21 int CD23 high FO B cells and maintained this pheno type after adoptive transfer (Fig. 3 F) . The B18 IgH chain con fers NPspecificity when paired with an Ig light chain (Jack et al., 1977; Reth et al., 1978; Bothwell et al., 1981) , effec tively increasing the NPspecific cells to 5% of the B cell population (unpublished data). Before immunization, the adoptively transferred FO B cells comprised 2.5% of the total splenic B cell compartment, and thus 0.1% of the B cells in the recipient were IgM a (B18) and NP specific (unpublished data).
After immunization with NPFicoll alone, adoptively transferred FO B cells generated a relatively weak and de layed NPspecific IgG2a response (Fig. 3 F) . As predicted, intact (Belperron et al., 2005 (Belperron et al., , 2007 . MZ B cells are retained within the MZ by integrin adhesion and are released into circulation by administration of antiintegrin mAbs (Fig. S2, A and B; Lu and Cyster, 2002) . Consistent with the splenec tomy data, depletion of MZ B cells led to a large reduction in the NPspecific IgM response to NPFicoll ± poly(I:C) at 4 d after immunization as compared with controls (Fig. 3 D) . Although a similar reduction in NPspecific IgM was not ob served at day 7 after immunization, this time point coincided with the return of MZ B cells to the spleen after integrin treatment and MZ B cell depletion (Fig. S2) . In contrast, mice depleted of MZ B cells generated equivalent poly(I:C) elicited NPspecific IgG2c responses at all time points evalu ated (Fig. 3 D) . Although these results do not formally eliminate a role for MZ B cells in the poly(I:C)induced IgG2c response, they illustrate that MZ B cells do not make a significant contribution to this response.
It remained possible that MZ B cells relocated outside the spleen but were still responsive to poly(I:C) and able to gen erate NPspecific IgG2c from this extrasplenic site. How ever, this was excluded as the frequency of splenic NPspecific IgG2c ASCs generated upon immunization with NPFicoll + poly(I:C) was the same regardless of MZ B cell depletion (Fig. 3 E) . These findings strongly suggest that FO B cells are the predominant source of the poly(I:C)induced IgG2c antibody response to the TI2 antigen NPFicoll. A mixture of bone marrow cells from B6.C20 (Igh a ) and Tlr3 / (Igh b ; experimental chimeras; filled) or B6.C20 and wild-type C57BL/6 (Igh b ; control chimeras; open) was adoptively transferred to lethally irradiated B6.C20 hosts. 8 wk after reconstitution, chimeras were immunized and NP-specific antibody measured in preimmune and day-7 sera. Reconstitution frequencies of IgM a -and IgM b -expressing B cells were measured as described in the Materials and methods and found to be equivalent between both experimental and control chimeras. Symbols represent individual chimeric mice, and horizontal bars indicate geometric mean. Data were combined from two independent experiments with five to six mice per group. n.d., not detected. reduction observed in the doubledeficient mice implicates both TLR3 and MDA5 in the recognition of poly(I:C) and sub sequent induction of a classswitched IgG2c B cell response.
The requirement for direct TLR signaling by B cells dur ing antibody responses has been the subject of recent debate (Pasare and Medzhitov, 2005; Gavin et al., 2006; Barr et al., 2007 Barr et al., , 2009 Jegerlehner et al., 2007; MeyerBahlburg et al., 2007) . Thus, we next questioned whether B cell-autonomous TLR3 signaling was required for the poly(I:C)induced NP Ficoll IgG2c response. To address this, we generated mixed bone marrow chimeras whereby wildtype (B6.C20Igh a ) and either Tlr3 / or Tlr3 +/+ (Igh b ) B cells were juxtaposed in direct competition with each other in recipient mice, and we measured the capacity of both populations to generate an IgG2a/c antibody response to NPFicoll + poly(I:C) (Fig. 4 B) . In these chimeras, TLR3 / (Igh b ) B cells mounted equiv alent NPspecific IgG2c responses upon immunization with NPFicoll + poly(I:C) as compared with wildtype (C57BL/ 6Igh b ) B cells in control chimeras (Fig. 4 B) . These results demonstrate that direct TLR3 signaling by B cells is not re quired for poly(I:C)induced TI2 IgG2c responses. Further more, these findings suggest that downstream secondary innate cytokine signals induced by PRR signaling may suffice in promoting B cell IgG2c antibody responses. poly(I:C) markedly enhanced both the magnitude and kinet ics of the NPspecific IgG2a response produced from FO B cells in vivo (Fig. 3 F) and similar to that elicited by poly(I:C) in wildtype mice (Fig. 1 A) . Similar findings were found when fivefold fewer (10 7 ) LN cells were transferred (unpub lished data). These findings directly demonstrate that FO B cells are able to generate IgG2c/a antibody responses to a TI2 antigen and, more importantly, show that this response is both accelerated and amplified by poly(I:C). Collectively, these results reveal that FO B cells provide a rapid and robust innatelike IgG2c antibody response to a TI2 antigen elic ited by poly(I:C).
Poly(I:C)-induced NP-specific IgG2c does not require TLR3 signaling by B cells
As a dsRNA analogue, poly(I:C) is recognized by both TLR3 and MDA5 PRRs in vivo (Alexopoulou et al., 2001; Gitlin et al., 2006; Kato et al., 2006) . To assess the in vivo contribu tion of these PRRs in the poly(I:C)induced IgG2c antibody response, Tlr3 / and Mda5 / single and compound mutants were immunized with NPFicoll + poly(I:C). These results re vealed modest but significant reductions in NPspecific IgG2c in the absence of either TLR3 or MDA5 that were additive in Tlr3 / Mda5 / double mutants (Fig. 4 A) . The combined in wild-type and Ifnar1 / mice measured from sera collected at days 0 and 7 after immunization with NP-Ficoll + poly(I:C). Symbols represent individual mice, and bars represent geometric means. Data were combined from two independent experiments with three to five mice per group per experiment. *, P ≤ 0.005. (B) C57BL/6 mice were immunized with 5 µg NP-Ficoll alone or in the presence of 100 µg Pam3CSK4 (TLR1/2), 100 µg poly(I:C) (TLR3), 100 µg 3M-012 (TLR7), or 8 × 10 5 U rIFN-11. NP-specific IgG2c responses were measured from sera collected preimmune (day 0) and at 7 d after immunization. Symbols represent individual mice, and horizontal bars indicate geometric mean. Shown is one representative of two independent experiments performed, with four mice per group. (C) Mixed bone marrow chimeras were generated as described in Fig. 2 B, except that experimental chimeras were generated from the transfer of Ifnar1 / (Igh b ) + B6.C20 (Igh a ) bone marrow. After reconstitution, chimeric mice were immunized with NP-Ficoll + poly(I:C) and NP-specific IgM a , IgM b , IgG2a, and IgG2c serum antibody responses measured preimmune (day 0) and at 7 d after immunization. Symbols represent individual mice, and horizontal bars indicate geometric mean. Representative data are from one experiment shown of two independent experiments performed, with four mice per group. n.d., not detected. *, P < 0.05.
IFNinducing TLR7 agonist produced NP specific IgG2c antibody responses similar to that induced by poly(I:C) (Fig. 5 B) . Conversely, the Pam3CSK4 TLR1/2 agonist did not promote NPspecific IgG2c above levels seen with antigen alone (Fig. 5 B) . These findings indicate that type I IFNinducing adjuvants promote classswitching to IgG2c during the TI2 antibody response. Fur thermore, these results are consistent with results showing that type I IFN augments particular iso types during the B cell antibody response to soluble protein antigens and viruses (Finkelman et al., 1991; Le Bon et al., 2001; Coro et al., 2006; Heer et al., 2007) .
We next considered whether we could bypass the re quirement for signaling through PRRs altogether by directly providing exogenous type I IFN during immunization. Mice immunized with NPFicoll and a single administration of rIFN were found to mount significantly higher levels of NPspecific IgG2c than NPFicoll alone (Fig. 5 B) . Although the magnitude of the IgG2c response elicited by rIFN im munization was reduced compared with poly(I:C) immuni zation, it was nevertheless notable that a single treatment induced a considerable IgG2c antibody response after 1 wk. (Fig. 5 C) .
Upon immunization with NPFicoll + poly(I:C), wild type (B6Igh b ) B cells in control chimeras mounted significant Type I IFN mediates poly(I:C)-induced antigen-specific IgG2c during the TI-2 antibody response Both TLR3 and MDA5 dsRNAsensing receptors are capable of recognizing poly(I:C) to induce a rapid type I IFN response (Alexopoulou et al., 2001; Gitlin et al., 2006; Kato et al., 2006; Longhi et al., 2009) . Given the accelerated IgG2c response to poly(I:C), we assessed the contribution of type I IFN to this response by immunizing Ifnar1 / mice. These results showed that the NPspecific IgG2c response to poly(I:C) immunization was reduced 90% in Ifnar1 / mice compared with wild type (Fig. 5 A) and inversely mirrored by a modest but significant increase in the NPspecific IgM response over wildtype controls (Fig. 5 A) . These findings demonstrate that type I IFN signaling is necessary for efficient induction of the TI2 IgG2c antibody response promoted by poly(I:C).
Type I IFN is an early hallmark of the antiviral innate im mune response initiated from the recognition of viral PAMPs. Thus, we predicted that the instruction to class switch to IgG2c during the TI2 antibody response would be a general property of all PAMPs capable of stimulating endogenous type I IFN production. To test this, we immunized mice with a representative group of TLR agonists known to stim ulate type I IFN (TLR7 agonist, 3M012; Gorden et al., 2005) or not (TLR1/2 agonist, Pam3CSK4; Longhi et al., 2009) and measured the IgG2c antibody response elicited to NPFicoll. As predicted, mice immunized with a type I purity from naive C57BL/6 mice and separately incubated with the indicated stimuli in vitro for 6 or 10 h. After stimulation, surface expression of CD69 (6 h) or CD86 (10 h) was subsequently assessed in both B cell populations by flow cytometry and data depicted as histograms. The following stimuli and doses were used: (B) rIFN- at 1, 10, or 100 U/ml; (C) rIFN- at 1 U/ml and anti-IgM F(ab) 2 at 10 µg/ml; (D) LPS at 10 µg/ml. Med, medium. Data are representative from at least two independent experiments.
Overall, these data demonstrate that IFN selectively acts on BCRstimulated FO, but not MZ, B cells to elevate CD69 surface expression. Type I IFNmediated surface expression of CD69 is inversely correlated with S1P1 chemo attractant receptor responsiveness (Shiow et al., 2006) , suggesting that selective CD69 expression by antigen experienced FO B cells could alter the trafficking of these cells during a response.
DISCUSSION
Study of B cell antibody response to hapten model antigens over the last several decades has provided considerable insight into how humoral immunity deals with different types of antigens. In particular, the reductionist nature of these model antigens facilitated our understanding of how different B cell subpopulations respond to distinct antigens. However, it is now evident that extrapolating from these studies is limited with respect to modeling humoral immunity to physiological pathogens. Pathogens such as viruses and bacteria not only present TI and TD antigens to B cells but also display a vari ety of PAMPs capable of alerting the innate immune system. This study addresses how these PAMPs influence humoral immunity to TI2 antigens.
The most dramatic changes elicited by poly(I:C) to the TI2 antibody response were measured in the acceleration of the kinetics and overall increase in the magnitude of the antigenspecific IgG2c response. Heightened production of IgG2c is significant, as this isotype is the most efficient IgG subclass for antipathogen FcRmediated effector functions (Nimmerjahn and Ravetch, 2005) and has long been recog nized as the predominant isotype elicited by viral infections (Coutelier et al., 1987) . Thus, these findings support the no tion that PAMPs polarize antibody responses to those iso types best suited to deal with particular pathogens (Janeway, 1989) . We further show that during the TI2 antibody re sponse, poly(I:C) promotes a persistence of elevated levels of antigenspecific IgG2c serum antibody, which are similar to those previously shown for TD antibody responses (Le Bon et al., 2001 ). The durability of this enhanced response has implications for vaccine design given the importance of neu tralizing antibody concentration in providing efficacious antiviral protective immunity Pulendran, 2009) .
Generally, pathogenspecific antibody responses divert from characterized haptenspecific responses, as they are typ ically faster and elicit IgG isotypes earlier than antihapten responses . We show that including a type I IFNinducing PRR agonist with the NP Ficoll TI2 antigen results in a rapid antihapten IgG2c re sponse. This classswitched antihapten response more closely reflects previously characterized antiviral and antimicrobial antibody responses with regard to kinetics, isotype specificity, and extrafollicular antibody production, illustrating the ap plicability of these studies to model pathogens. For instance, among the many arms of the influenza antibody response, NPspecific IgM b and IgG2c antibody responses (Fig. 5 C) . As predicted from immunization of IFNR1 / mice (Fig. 5 A) , Ifnar1 / (Igh b ) B cells also produced an NPspecific IgM b antibody response (Fig. 5 C) . In contrast, Ifnar1 / (Igh b ) B cells did not generate any significant NPspecific IgG2c antibody (Fig. 5 C) . Moreover, wildtype (B6.C20Igh a ) B cells in competition with IgM b expressing B cells in both sets of chimeras made comparable NPspecific IgM a and IgG2a antibody responses (Fig. 5 C) , further eliminating a role for non-B cell hematopoietic populations and indicating a B cell-autonomous defect. This impaired ability of Ifnar1 / B cells to class switch to IgG2c was not a result of abnormal B cell development, as Ifnar1 / mice have normal composi tions of mature splenic B cell compartments (Le Bon et al., 2006; Green et al., 2009) .
These data show that Ifnar1 / B cells contribute normally to TI2 IgM responses but that in the presence of type I IFNinducing PAMPs such as poly(I:C), they are unable to generate antigenspecific IgG2c TI2 antibody response. This establishes an in vivo role for type I IFN receptor signaling by FO B cells in directly promoting the production of the antiviral IgG2c iso type and, thus, enhancing the B cell antibody response.
IFN- acts selectively on BCR-activated FO B cells to increase CD69 expression
FO and MZ B cells express similar levels of the type I IFN receptor (Fig. 6 A) , excluding differential receptor expression as an origin for the dominant FO B cell response to type I IFN promoting adjuvants. Thus, we predicted that type I IFN differentially influenced FO B cells relative to MZ B cells.
Type I IFN can directly activate B cells in vitro (Morikawa et al., 1987; Braun et al., 2002; Coro et al., 2006; Kamphuis et al., 2006; Shiow et al., 2006) and in vivo (Chang et al., 2007; Coro et al., 2006; Shiow et al., 2006) . Thus, we assessed the ability of IFN to activate either FO or MZ B cells and found that both populations displayed similar sensi tivity and kinetics to recombinant IFN as measured by induc tion of surface expression of CD69 and CD86 activation antigens (Fig. 6 B and not depicted) .
We next questioned whether FO and MZ B cells might differ in their response to IFN stimulation in the context of BCRmediated activation similar to the situation during an antibody response. Concomitant treatment of FO B cells with antiIgM and suboptimal levels of IFN led to CD69 expression to levels greater than those detected with anti IgM stimulation alone (Fig. 6 C) . In contrast, antiIgM treatment of purified MZ B cells failed to increase CD69 expression to any appreciable level and, importantly, this expression was not enhanced by concomitant IFN treat ment (Fig. 6 C) . The inability of antiIgM to induce CD69 expression on MZ B cells was not true of all activation markers as antiIgM ± IFN increased CD86 expression similar to FO B cells (Fig. 6 C) . Furthermore, MZ B cells exhibited increased sensitivity to LPS activation as mea sured by CD86 expression (Fig. 6 D) as previously shown (Oliver et al., 1999) . in TLR3 / MDA5 / double knockout chimeric mice (Longhi et al., 2009) , which is similar to our findings with the B cell antibody response. As RIGI is also a cytosolic PRR capable of recognizing lowmolecularwt poly(I:C) to signal type I IFN production (Kato et al., 2008) , we envision that this dsRNA sensor is likely responsible for the type I IFN that promotes a modest increase in NPspecific IgG2c in the double mutants. Ultimately, our data demonstrate that nonTLRinnate signals, such as type I IFN, can substitute for TLR sensing of nonself to augment antibody responses. This redundancy in the recognition of poly(I:C) by multiple dsRNA sensing receptors highlights the importance of IFN/ as a global nonself warning signal for enhancing the efficiency of antipathogen antibody responses. Indeed, it has been noted that all vertebrates examined have immune systems com prised by T and B lymphocytes and genes encoding IFN and IFN (Stetson and Medzhitov, 2006) , suggesting that the type I IFNmediated innate response is closely associated with adaptive immunity.
For humoral immunity, type I IFN elaborated during antiviral responses promotes IgG2a/c antibody production in vivo (Finkelman et al., 1991; Heer et al., 2007) . However, the role for B cell-intrinsic signaling by type I IFN to directly instruct IgG2c class switching in vivo is unclear. Specifically, signaling through the IFNR expressed by B and T cells has been shown to enhance IFN-mediated IgM and IgG re sponses to soluble proteins (Le Bon et al., 2006) . In opposi tion, direct IFNR signaling by B cells has been found to be unnecessary for the antiviral IgG2c response during acute in fluenza infection (Coro et al., 2006) . Using a chimeric B cell competition model, we demonstrate that B cell-autonomous IFNR signaling does induce IgG2a/c switching in vivo during systemic type I IFN responses, such as that elicited by poly(I:C). The discordance between our findings and other studies likely illustrates the complexity of additional inflam matory cytokines, beyond type I IFN, that are elicited during viral infections and that also regulate the instruction to switch between Ig subclasses (Coro et al., 2006) .
A potential mechanism to account for the type I IFN induced response from FO B cells is suggested by the ability of type I IFN to modulate CD69 expression on FO B cells. It has been shown that IFNinduced CD69 surface expression inhibits lymphocyte egress from lymphoid organs by the concomitant loss of sphingosine1phosphate responsiveness (Shiow et al., 2006) . In accord with this, virusinduced IFN / also causes accumulation of circulating FO B cells to re gional lymph nodes early during antiviral responses (Chang et al., 2007) . The enhanced response by FO B cells to up regulate CD69 in response to IFN and BCRmediated activation would presumably ensure that these normally recirculating B cells would be retained within secondary lymphoid organs where they can receive further noncognate secondary signals necessary for TI2 antibody responses (Chang et al., 2007) . In addition, as TI2 antigens would likely be associated with TD antigens within a pathogen, the a localized IgG2c extrafollicular B cell antibody response is de tectable within a few days in mediastinal lymph nodes after intranasal infection (Coro et al., 2006) . Similarly, vesicular stomatitis virus has been demonstrated to have a highly or ganized antigenic capsid capable of eliciting TI antibody responses (Bachmann et al., 1995) while simultaneously inducing an early isotypeswitched antibody response (Bachmann et al., 1996) . These early classswitched responses are not exclusive to antiviral responses, as Salmonella typhimurium likewise promotes an extrafollicular IgG2c switched plasma cell response detectable 4 d after infection (Cunningham et al., 2007) . Thus, the common feature of this rapid and highly efficient IgG subclass elicited to both major antipathogen responses further highlights the physiological and biological relevance of our findings.
Mature naive murine B cells constitutively express tran scripts for the majority of TLRs (Barr et al., 2007; Genestier et al., 2007; Gururajan et al., 2007) , and mature B cells can respond to TLR3 signaling in vitro (Alexopoulou et al., 2001) . The requirement for direct TLR signaling by B cells during antibody responses has been controversial. In particu lar, previous studies have demonstrated a B cell-intrinsic requirement for TLR signaling in the generation of B cell antibody responses (Pasare and Medzhitov, 2005; Jegerlehner et al., 2007) . Conversely, studies have also provided evidence that disregards TLR signaling for initiating antibody responses and supporting an instructive role for TLRs in augmenting antibody isotypes (Gavin et al., 2006) . Our results demon strate a minor role for TLR3 signaling in optimal induction of IgG2c by poly(I:C), supporting previous studies showing that TLR signaling is largely unnecessary for efficient anti body responses (Gavin et al., 2006) . However, the ability of Tlr3 / B cells to mount normal antibody responses in re constituted hosts clearly negates a role for B cell-intrinsic TLR3 signaling in IgG2c induction by poly(I:C). Discrepan cies observed in the role of B cell-intrinsic TLR signaling may be explained by a lack of direct conjugation of the TLR agonist with antigen, whereby conjugation would allow for the TLR agonist to be directed through BCRmediated internalization to responding B cells for concomitant TLR signaling (EcklDorna and Batista, 2009) . Our data do not exclude whether autonomous B cell expression of other PRRs, such as MDA5, is required for the IgG2c TI2 anti body response. Whether B cell-intrinsic RIGI-like helicase signaling may affect antibody responses remains unclear but would be interesting to address with a TLR3 / MDA5 / B cell chimeric model similar to that used here.
Our findings indicate that poly(I:C) is recognized pre dominantly by TLR3 and MDA5 for subsequent indirect in duction of the TI2 IgG2c antibody response through type I IFN. However, we note that in Tlr3 / Mda5 / double knockout mice, poly(I:C) remains able to induce NPspecific IgG2c but is 80% reduced compared with wild type (Fig. 4 A) , suggesting residual type I IFN induction. In ac cordance with this, it has recently been reported that poly(I:C) induction of CD4 T cell responses is incompletely abolished
MATERIALS AND METHODS
Mice. C57BL/6 mice (The Jackson Laboratory) were used directly or bred and maintained within the Biological Resource Center at National Jewish Health (NJH; Denver, CO). C57BL/6Igh B18/B18 ;Igh a mice (Sonoda et al., 1997 ; gift from K. Rajewsky, Harvard University, Boston, MA) and B6.C20 mice (C57BL/6 mice congenic for Igh a ; gift from L. Herzenberg, Stanford University, Palo Alto, CA) were both bred and maintained within the Bio logical Resource Center at NJH. Ifnar1 / mice (Müller et al., 1994) on the C57BL/6 genetic background were provided by P. Marrack (NJH, Denver, CO). MDA5 / (Gitlin et al., 2006) , Tlr3 / , and Mda5 / , Tlr3 / mice on C57BL/6 genetic backgrounds were maintained at Washington University (St. Louis, MO). Tlr3 / mice (Alexopoulou et al., 2001) on the C57BL/6 background were provided by R. Flavell (Yale University, New Haven, CT) and also bred and housed within the NJH Biological Resource Center. Animals were used between 8 and 12 wk of age, unless otherwise specified. All experiments were performed in accordance with NJH and Washington University Institutional Animal Care and Use Committees.
Flow cytometric analyses and antibodies. Spleen and lymph node cells were harvested and stained according to standard protocols. Fluorescently labeled mAbs against the following mouse surface antigens were used for staining and either purchased or isolated and conjugated in our laboratory: B220 (RA36B2; BD and eBioscience), IgM (R3324.12; hybridoma), IgM b (AF678; hybridoma), CD21 (7G6; hybridoma), CD19 (1D3; hybrid oma and BD), CD1d (1B1; eBioscience), CD69 (H1.2F3; eBioscience), CD86 (GL1; eBioscience), CD23 (B3B4; BD), TCR (H57597; BD), IgH B18 (antiidiotype; Ac146; hybridoma; Reth et al., 1979) , IgM a (DS1; BD), Ig (JC51; SouthernBiotech), IgD (1126c; BD), CD11a (2D7; BD), IFNR1 (MAR15A3; BioLegend), and Mouse IgG1, isotype control (MOPC21; BD). For detection of NPspecific B cells by flow cytometry, cells were stained with 4Hydroxy3nitrophenylacetyl hapten conjugated to Phycoerythrin (NP 40 -PE; Biosearch Technologies) after standard flow cytometric staining protocol. The secondary detection reagent for detecting biotinconjugated antibodies by flow cytometry was streptavidinPE (eBio science). Flow cytometric analyses were performed by acquiring data on either a FACSCalibur (BD) or a BD LSRII (BD) and with FlowJo v8.8.6 software (Tree Star, Inc.).
Immunizations.
Mice were immunized i.p. with 5 µg NP (4Hydroxy3 nitrophenylacetic) hapten conjugated to NP-Ficoll (AminoEthylCarboxy MethylFICOLL) at NP 32 -, NP 41 -, or NP 50 -Ficoll valencies (Biosearch Technologies). Unless otherwise specified, the following doses of adjuvants or cytokines were included with NPFicoll in immunizations as detailed: 100 µg poly(I:C) (polyinosinepolycytidylic acid; InvivoGen), 100 µg Pam3CSK4 (NPalmitoylS [2,3bis(palmitoyloxy) 
(2, RS)propyl][R]
Cys[S]Ser[S]Lys4; InvivoGen), 100 µg 3M012 (33080; TLR7 agonist; 3M Pharmaceuticals; gift from R. Kedl, NJH), or 8 × 10 5 U recombinant mouse IFN11 (Genbank accession no. AY225954; gift from R. Kedl, NJH). Antigens, adjuvants, and cytokines were either purchased as endo toxin free (≤0.125 EU/mg) or tested by an endpoint chromogenic Limulus Amebocyte Lysate (LAL) assay (Cambrex) and found to be at levels ≤0.1 EU per mouse for immunization.
NP-specific ELISAs.
To measure NPspecific serum antibody responses, 96well flatbottom MaxiSorp MicroWell plates (Thermo Fisher Scientific) were coated overnight with 2 µg/ml (4Hydroxy3iodo5nitrophenylacetyl) NIP 15 -BSA (Biosearch Technologies) diluted in PBS at 4°C. Plates were washed once (PBS, 0.1% Tween 20; Thermo Fisher Scientific), blocked (PBS, 1% BSA, and 0.05% NaN 3 ) for a minimum of 2 h at 37°C, and washed once again. For capture of antigenspecific antibodies, sera were initially di luted 1:20 and subsequent threefold serial dilutions were made into blocking buffer and incubated overnight at 4°C. Plates were washed three times be fore incubation with an alkaline phosphatase (AP)-conjugated goat antimouse isotypespecific detection antibody (SouthernBiotech) for 1 h at 37°C. After three washes, plates were developed by the addition of alkaline loss of S1P1 responsiveness would also be expected to direct TI2 antigenactivated B cells to the T-B cell border where associated TD antigens could be presented to antigenspecific T cells.
Protective humoral immunity to pathogens is contributed by distinct B cell subsets with unique activation requirements and response patterns. Studies from dissected model patho gens, such as S. pneumoniae and influenza, have taught us that multifaceted protective humoral immune responses are com prised by a collection of antibodies derived from distinct B cell subsets (Baumgarth et al., 1999 (Baumgarth et al., , 2008 Snapper, 2006) . Features that dictate which B cell subset responds have been characterized, including the intrinsic responsiveness of each B cell subset and the biochemical properties of the antigens. Yet, it is still not understood how innate signals encountered during these infections dictate which B cell subset participates in each facet of the antibody response. The TI2 response to NPFicoll has been characterized by the domination of IgM and IgG3 isotypes derived from MZ B cells (Otipoby et al., 1996; Guinamard et al., 2000; Samardzic et al., 2002; Shih et al., 2002) . We demonstrate in this paper that in the pres ence of type I IFN innate signals, FO B cells are rapidly pro moted to participate in a switched TI2 antibody response through B cell-intrinsic IFN/ signaling that leads to antigenspecific IgG2c antibody production. Whether type I IFN recruits additional FO B cells to respond to a TI2 anti gen or promotes enhanced clonal expansion of responding antigenspecific FO B cells remains to be established.
Rapid lowaffinity extrafollicular innatelike antibody responses are crucial to providing early acquired immunity against pathogens. This study provides the first direct evi dence for an innatelike switched FO B cell antibody re sponse to a TI2 antigen. The participation by FO B cells to this switched TI2 response was unexpected given the long standing model that FO B cells are a slower responding B cell subset and predominately produce higher affinity post germinal center antibodies during TD responses McHeyzerWilliams, 2003) . Economically, one rationale behind the enhanced contribution of FO B cells to providing the IFN/-induced IgG2c response, as opposed to the subset which produces the TI2 IgM re sponse, is that this division of labor allows for IgG2c induc tion but not at the expense of the crucial initial IgM response. Furthermore, this division of labor illustrates the importance of both arms of the antipathogen humoral response: a rapid IgM response to provide antibody capable of neutralizing and controlling the infection and a robust and highly efficient IgG2c response effective at specialized FcRmediated clear ance Ravetch, 2005, 2008) . These findings propose a novel role for FO B cells in responding to innate signals in vivo to participate in innatelike antibody responses. Future studies will be required to address whether a discreet subset of innate FO B cells exist that solely have the capacity to respond in this manner or whether this phenomenon is a general characteristic of all FO B cells recruited in response to particular innate signals.
Epson). Developed spots were counted visually from the scanned images and the frequency of NPspecific ASCs per total number of cells plated was enumerated.
Splenectomy operations. For both vital splenectomy and sham opera tions, 6wkold C57BL/6 mice were anesthetized by intraperitoneal injection of 100 mg/kg ketamine and 10 mg/kg xylazine, followed by administration of a subcutaneous injection of 0.5 mg/kg buprenorphine for pain. Once sedated, a 1-1.5cm incision was made on the upper left abdomen through both the peritoneal wall and skin. For splenectomized animals, the spleen was exteriorized and the splenic artery and efferent venule were each ligated. For shamoperated mice, the spleen was gently replaced back into the abdo men. For all animals, the abdominal wall was closed by placing one to two sutures through the peritoneal membrane, and subsequently two wound clips were placed to adjoin the exterior skin of the incision. Postoperative care included administration of 1 ml of subcutaneous saline, rest near an in direct heat source, and monitoring until full motility was regained. Pain management was achieved by subcutaneous injections of 0.5 mg/kg bu prenorphine every 12 h for 2-3 d after surgery. Mice were allowed to re cover for 21-29 d after surgery, at which time the total serum IgM was determined to be equivalent between the shamoperated and splenecto mized groups. At 23-32 d after operation, mice were immunized and serum NPspecific antibody responses measured by ELISA as described.
MZ B cell depletion.
For selective MZ B cell depletion in vivo, a protocol was used that was similar to a previously published protocol (Belperron et al., 2005 (Belperron et al., , 2007 . In brief, C57BL/6 mice were injected i.p. with 100 µg each of unconjugated purified rat IgG2a anti-mouse CD11a (Integrin  L , LFA1; clone M17/4; hybridoma) and rat IgG2b anti-mouse CD49d (Integrin  4 ; VLA4; clone PS/2; hybridoma) mAbs diluted together in sterile PBS. Con trol mice were injected with 100 µg each of functional grade purified rat IgG2a (clone eBR2a; eBioscience) and rat IgG2b isotype control antibodies (clone eB149/10H5; eBioscience) also diluted in PBS. 3 h after injection of antibodies, mice were bled and PBLs stained for the mature B cell markers CD21 and CD1d to verify MZ B cell release into blood. Greater than 80% of MZ B cells are depleted entirely from the spleen up to 10 d after injection of antiintegrin antibodies (Fig. S2 A) , and by 14 d after treatment >60% of normal frequencies of MZ B cells have returned to spleen (Fig. S2 A) . Approximately 10% of the antiintegrin antibodies injected remain within circulation 4 d after injection and are essentially completely cleared by 7 d after injection (Fig. S2 C) . However, surface integrin expression is also down modulated by the anti4/L treatment on remaining T and B lymphocytes up to 4 d after injection (Fig. S2D) . Thus, for MZ B cell depletion experi ments, mice were rested for 7 d after injection of antiintegrin antibodies and before immunization (Fig. S2 E) to allow both for clearance of rat anti 4/L antibodies (Fig. S2 C) and for remaining T and B lymphocytes to regain wildtype levels of surface integrin expression (Fig. S2 D) . 7 d after injection of antibodies, mice were immunized with NPFicoll ± poly(I:C) as described in Fig. S2 E. Sera were collected either the day before immuni zation (preimmune) or at 4 and 7 d after immunization, and serum NP specific antibody responses were measured as described. At 7 d after immunization, splenocytes were harvested and the frequency of NPspecific ASCs was evaluated by ELISPOT. Depleting antiintegrin antibodies were tested by the LAL assay and found to be at levels ≤0.1 EU/ml.
To determine the clearance of serum rat IgG antibodies over time in this model, serum was collected from mice injected with either rat IgG anti integrin and isotype control antibodies and analyzed for the presence of rat IgG by ELISA. In brief, plates were coated with 10 µg/ml of unlabeled goat anti-rat IgM + IgG (H + L chain specific, absorbed against mouse Ig) anti body in PBS overnight at 4°C. After washing (PBS and 0.1% Tween 20), plates were blocked for 3 h at 37°C with preimmune C57BL/6 mouse serum diluted 1:200 in PBS, 1% BSA, and 0.05% NaN 3 and subsequently washed twice. Sera and standards were diluted similarly as above and incubated over night at 4°C. Plates were washed three times, and bound antibodies were detected by incubation with APconjugated goat anti-rat IgG (H + L chain phosphatase substrate buffer consisting of 1 mg/ml 4Nitrophenyl phosphate disodium salt hexahydrate (Alkaline Phosphatase Substrate; SigmaAldrich) diluted in 1 M diethanolamine, 8.4 mM MgCl 2 , and 0.02% NaN 3 , pH 9.8, and absorbance values read at 405 nm (VersaMax ELISA reader; MDS Analytical Technologies). The following NPspecific mouse mAbs were used as standards to quantify the absolute concentration of NPspecific anti body present in the sera of immunized mice: B18  (NPspecific IgM; Reth et al., 1978) , S24/63/63 (NPspecific IgG3; Baumhäckel et al., 1982) , N1G9 (NPspecific IgG1; Cumano and Rajewsky, 1985) , S4310 (NP specific IgG2c; Reth et al., 1978) , and D313F1 (NPspecific IgG2b; gift from K. Rajewsky). In the cases where a standard was unavailable, the titer at an OD 50 was determined from the serial dilution curves for each sample.
For both adoptive transfer and mixed bone marrow chimera analyses, detection of NPspecific IgG2a or IgG2c serum antibodies by ELISA was accomplished with APconjugated AffiniPure goat anti-mouse IgG, Fc  Subclass 2a-specific (Jackson ImmunoResearch Laboratories), or AP conjugated AffiniPure goat anti-mouse IgG, Fc  Subclass 2c-specific (Jackson ImmunoResearch) antibodies, respectively. The detection of NPspecific IgM a or IgM b serum antibody responses was accomplished as previously described (Rubtsov et al., 2005) with either biotinconjugated mouse antiIgM a (DS1; BD) or biotinconjugated mouse antiIgM b (AF678; BD) antibodies, respectively. Plates were subsequently washed three times and bound antibody revealed by incubation with APconjugated Streptavidin (Southern Biotech).
For affinity maturation measurements, ELISAs were performed as in the previous paragraphs with the exception that plates were coated with either NP (4Hydroxy3nitrophenylacetyl) 4 -BSA or NP 16 -BSA capture antigens (Biosearch Technologies) diluted at 2 µg/ml. The ratio of highaffinity anti bodies bound to NP 4 -BSA relative to the total of both high and low affinity antibodies bound to NP 16 -BSA was calculated as previously described (Herzenberg et al., 1980; Cumano and Rajewsky, 1985) . In brief, the rela tive NP 4 /NP 16 binding ratio for a given sample was calculated as the OD 50 titer of serum antibodies bound to NP 4 -BSA divided by the OD 50 titer of antibodies bound to NP 16 -BSA. The NPspecific mAb S4310 (Reth et al., 1978) was used as a positive control for a highaffinity NPspecific IgG2c antibody with an affinities of K d = 2.4 × 10 8 M for NIP and K d = 2.8 × 10 7 M for NP (Cumano and Rajewsky, 1985) .
NP-specific ELISPOTS. NPspecific ASCs were measured in 96well flatbottom EIA/RIA highbinding plates (Costar; Corning) coated over night at 4°C with 2 µg/ml NIP 15 BSA diluted in 0.05 M K 2 HPO 4 , pH 8.0. Plates were washed three times with PBS before blocking with warm PBS and 1% gelatin (SigmaAldrich) at 37°C for a minimum of 1 h. Plates were washed again three times with PBS before incubation with cells. Cells were isolated from spleen, bone marrow, or lymph nodes at the times indicated after immunization and seeded in duplicate at a starting density of 0.25-1 × 10 7 total viable cells per 100 µl in the first well, and threefold serial dilutions were performed down the plate. For those ELISPOTs performed on lymph node cells, lymph nodes harvested from three mice within the same treat ment group were pooled together to constitute a single sample. Cultured cells were incubated at 37°C in 5% CO 2 for 6 h in complete IMDM (Invit rogen) supplemented with 10% heatinactivated FBS (Biosource, Invitro gen, or Gemini BioProducts), 2 mM GlutaMAXI (Invitrogen), 100 U/ml Penicillin (Invitrogen), 100 µg/ml Streptomycin (Invitrogen), and 0.05 mM 2mercaptoethanol (SigmaAldrich). Plates were then washed once with H 2 O and 0.05% Tween 20 for 10 min at room temperature and subse quently three times with PBS and 0.1% Tween 20. Secreted antibody was detected by incubating plates with an isotypespecific APconjugated goat anti-mouse Ig (SouthernBiotech) diluted in warm PBS, 1% gelatin, and 0.05% Tween 20 for 1 h at 37°C. After three washes (PBS, 0.1% Tween 20), plates were developed overnight at 4°C with 1 mg/ml 5Bromo4 chloro3indolyl phosphate ptoluidine (SigmaAldrich) salt substrate diluted in an alkaline buffer composed of 0.1 M 2amino2methyl1propanol, 0.01% NaN 3 , 0.5 mM MgCl 2 , and 0.007% Triton X405, pH 10.25. Plates were washed four times with deionized H 2 O, allowed to dry in the dark at room temperature, and scanned (Perfection 2450 Photo Scanner; in PBS, 2% BSA, and 0.05% Tween 20 at room temperature. Sections were stained with antibody mixtures diluted in PBS for 30-60 min at room tem perature in the dark, followed by three 5min washes with shaking with PBS. Incubation and washing steps were repeated in the cases where a sec ondary detection reagent was used. Sections were dried, mounted with Bion IFA mounting medium (Bion Enterprises, Ltd.), visualized at room tempera ture with a microscope (Axiovert 200M; Carl Zeiss, Inc.) using a 3i Marianis System, and analyzed with Slidebook 4.0 software (Intelligent Imaging In novations). Antibodies and secondary reagents used for immunofluorescence histological detection included the following: FITCconjugated rat antimouse CD169 (MOMA1; AbD Serotec), Alexa Fluor 546-conjugated rat anti-mouse IgM (R3324.12; our laboratory), Alexa Fluor 647-conjugated mouse anti-mouse IgD (1.3-5; our laboratory), biotinconjugated rat antimouse Lambda (JC51; SouthernBiotech), streptavidin-FITC (BD), and Cy5conjugated goat anti-mouse IgG, Fc Subclass 2c specific (Jackson ImmunoResearch Laboratories). All Alexa Fluor-conjugated antibodies were purified and conjugated in our laboratory using Alexa Fluor Protein Labeling kits (Invitrogen).
Statistical and data analyses. Data were graphed and analyzed using Prism version 5.0a (GraphPad Software). Statistical significance was assessed with a Student's t test with unequal variance, and the appropriateness of one tailed or twotailed significance was determined on an individual experiment basis. Pvalues ≤0.05 were considered significant. Where appropriate, data were expressed as the geometric mean ± SEM, unless otherwise stated.
Online supplemental material. Fig. S1 shows dose response of poly(I:C) on the production of NPspecific IgG2c and lack of polyclonal IgG2c pro duction. Data presented in Fig. S2 characterizes the kinetics of MZ B cell depletion by antiintegrin treatment. Online supplemental material is avail able at http://www.jem.org/cgi/content/full/jem.20092695/DC1. Adoptive cell transfers. Lymph node cells were harvested and purified from BL6Igh B18/B18 ;Igh a mice in IMDM supplemented with 5% FBS, washed twice (PBS), and resuspended in sterile PBS. Approximately 5 × 10 7 total lymph node cells were injected intravenously into each sexmatched C57BL/6Igh b recipient mouse. 1 d after cell transfer, recipient mice were immunized with NPFicoll ± poly(I:C) as described. Serum was collected before adoptive cell transfer (preimmune) and at 4 and 7 d after immuniza tion, and NPspecific antibody responses were subsequently measured by ELISA. For phenotypic confirmation, mice were left unimmunized and ver ification of transferred IgM a expressing B cells within the splenic FO B cell compartment of C57BL/6Igh b recipient mice 1 d after transfer was vali dated by flow cytometry.
Mixed bone marrow chimeras. Bone marrow cells were isolated from 5-7wkold C57BL/6 (Igh b ), B6.C20 (Igh a ), Tlr3 / (Igh b ), or Ifnar1 / (Igh b ) donor mice in IMDM supplemented with 5% FBS under sterile con ditions. Donor bone marrow cells were washed once with sterile PBS (Cell gro; Mediatech, Inc.), resuspended at 1.33-2.67 × 10 7 cells/ml in PBS, and mixed (Igh b + Igh a ) to yield a final concentration of 2 × 10 7 cells/ml for re constitution. A total of 4 × 10 6 bone marrow cells were injected intrave nously into each sexmatched lethally irradiated (1,000 rad) 6-8wkold B6.C20 recipients. Recipient mice were maintained on Septra food for 7-8 wk after reconstitution. At 8 wk after reconstitution, PBLs from chimeric mice were analyzed by flow cytometric analysis to ensure no significant differ ences were observed between the ratio of IgM b :IgM a B cell reconstitution frequencies in the experimental chimeras as compared with the control chi meras. Chimeric mice were immunized at 9 wk after reconstitution and serum NPspecific antibody responses were measured by ELISA as described. At 14 d after immunization, the ratio of IgM b :IgM a B cell reconstitution frequencies was determined within the chimeric splenic mature B cell com partments and found to be identical to those previously measured in the circulating B cell population.
In vitro stimulation. B cells were negatively enriched from naive C57BL/6 mice by depletion of CD43 + cells with magnetic cell sorting on LS columns (Miltenyi Biotec) with MACS buffer (PBS, 2 mM EDTA, and 0.5% BSA) according to the manufacturer's protocol. MZ (CD21 high CD1d high ) and FO (CD21 int CD1d int ) B cells were subsequently sorted based on surface expres sion of CD21 and CD1d to ≥94% purity using a MoFlo XDP Cell Sorter (Beckman Coulter) with Summit Software version 5.1.3.6886. Sorted MZ and FO B cells were cultured separately at 2.5-5 × 10 5 cells/ml in 1 ml of com plete IMDM in 24well flat bottom cell culture plates (CELLSTAR; Greiner BioOne) with the indicated stimuli at 37°C in 5% CO 2 . Stimuli and their concentrations cultured with cells included the following: 1-100 U/ml re combinant mouse IFN11 (PBL InterferonSource), 1-10 µg/ml AffiniPure F(ab) 2 goat antimouse IgM,  chain specific (antiIgM; Jackson Immuno Research Laboratories), and 0.1-10 µg/ml LPS (Escherichia coli O26:B6; SigmaAldrich). B cell activation was subsequently assessed as CD69 and CD86 cell surface marker upregulation measured by flow cytometry after stimulation for 6 or 10 h, respectively. Endotoxin levels of stimuli used for in vitro cultures were either measured by the LAL assay or purchased as <1 EU/µg.
Immunofluorescence histology. Spleens were harvested from mice 7 d after immunization and frozen in OCT compound (EM Sciences) at 80°C. Tissues were cut into 5-7µm sections and allowed to dry at room tempera ture. Unfixed sections were rehydrated with PBS for 20 min and blocked for 15-30 min with rat anti-mouse FcR blocking antibody (2.4G2) diluted
